Pharmacyte BiotechPMCB
13F holders, Q3 2024 (September 30)3holders −1
0new positions
1sold out
$1.60avg. 13F price*
At the end of Q3 2024, 3 institutions reported holding Pharmacyte Biotech Inc. (PMCB) in their 13F filings, down 1 from Q2 2024. 0 opened new positions and 1 sold out. The largest holders were Caldwell Sutter Capital, Inc. ($4), Carolina Wealth Advisors, LLC ($4) and Huntington National Bank ($0).
- Company
- Pharmacyte Biotech Inc.
- CUSIP
- 71715X104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $53 |
All 13F filers, Q2 2024 → Q3 2024: 27 shares sold, net −27 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Caldwell Sutter Capital, Inc. | 0.00% | No change | 2 | $4 |
| Carolina Wealth Advisors, LLC | 0.00% | No change | 2 | $4 |
| Huntington National Bank | 0.00% | No change | 1 | $0 |
"% of holder's portfolio" is PMCB's weight in each manager's 13F, not the share of Pharmacyte Biotech Inc. the manager owns.